This company has been marked as potentially delisted and may not be actively trading. Interpace Biosciences (IDXG) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesTrendsBuy This Stock IDXG vs. DGX, LH, DVA, CHE, CRVL, AMED, MD, AMN, CCRN, and GBSShould you be buying Interpace Biosciences stock or one of its competitors? The main competitors of Interpace Biosciences include Quest Diagnostics (DGX), Laboratory Co. of America (LH), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), and GBS (GBS). Interpace Biosciences vs. Quest Diagnostics Laboratory Co. of America DaVita Chemed CorVel Amedisys Pediatrix Medical Group AMN Healthcare Services Cross Country Healthcare GBS Interpace Biosciences (NASDAQ:IDXG) and Quest Diagnostics (NYSE:DGX) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, dividends, community ranking, earnings, risk, valuation and profitability. Which has more risk and volatility, IDXG or DGX? Interpace Biosciences has a beta of 0.76, suggesting that its share price is 24% less volatile than the S&P 500. Comparatively, Quest Diagnostics has a beta of 0.78, suggesting that its share price is 22% less volatile than the S&P 500. Does the media prefer IDXG or DGX? In the previous week, Quest Diagnostics had 54 more articles in the media than Interpace Biosciences. MarketBeat recorded 56 mentions for Quest Diagnostics and 2 mentions for Interpace Biosciences. Quest Diagnostics' average media sentiment score of 0.85 beat Interpace Biosciences' score of 0.00 indicating that Quest Diagnostics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Interpace Biosciences 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Quest Diagnostics 20 Very Positive mention(s) 4 Positive mention(s) 16 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Does the MarketBeat Community prefer IDXG or DGX? Quest Diagnostics received 225 more outperform votes than Interpace Biosciences when rated by MarketBeat users. However, 72.83% of users gave Interpace Biosciences an outperform vote while only 49.19% of users gave Quest Diagnostics an outperform vote. CompanyUnderperformOutperformInterpace BiosciencesOutperform Votes31972.83% Underperform Votes11927.17% Quest DiagnosticsOutperform Votes54449.19% Underperform Votes56250.81% Do institutionals & insiders have more ownership in IDXG or DGX? 5.7% of Interpace Biosciences shares are owned by institutional investors. Comparatively, 88.1% of Quest Diagnostics shares are owned by institutional investors. 5.5% of Interpace Biosciences shares are owned by company insiders. Comparatively, 8.2% of Quest Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Do analysts recommend IDXG or DGX? Quest Diagnostics has a consensus target price of $183.73, suggesting a potential upside of 5.75%. Given Quest Diagnostics' stronger consensus rating and higher probable upside, analysts clearly believe Quest Diagnostics is more favorable than Interpace Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Interpace Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Quest Diagnostics 0 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 2.69 Is IDXG or DGX more profitable? Interpace Biosciences has a net margin of 10.39% compared to Quest Diagnostics' net margin of 8.80%. Quest Diagnostics' return on equity of 15.07% beat Interpace Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Interpace Biosciences10.39% -8.09% 37.14% Quest Diagnostics 8.80%15.07%6.72% Which has better earnings and valuation, IDXG or DGX? Quest Diagnostics has higher revenue and earnings than Interpace Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInterpace Biosciences$40.21M0.07$800KN/AN/AQuest Diagnostics$10.16B1.91$871M$7.9121.97 SummaryQuest Diagnostics beats Interpace Biosciences on 14 of the 17 factors compared between the two stocks. Get Interpace Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDXG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IDXG vs. The Competition Export to ExcelMetricInterpace BiosciencesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.87M$4.35B$5.47B$7.82BDividend YieldN/A46.43%5.43%4.27%P/E RatioN/A30.7422.3918.44Price / Sales0.0753.01391.41101.46Price / Cash1.9951.0838.1834.62Price / Book-0.056.146.684.19Net Income$800,000.00$68.15M$3.22B$248.05M Interpace Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IDXGInterpace BiosciencesN/A$0.65-35.0%N/A-56.7%$2.87M$40.21M0.00152News CoverageGap DownHigh Trading VolumeDGXQuest Diagnostics4.6043 of 5 stars$174.10+7.6%$181.33+4.2%+29.4%$19.42B$9.87B22.6349,000Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews CoverageLHLaboratory Co. of America4.6693 of 5 stars$218.36+2.9%$268.77+23.1%+15.2%$18.23B$13.01B24.7175,500Upcoming EarningsShort Interest ↑Positive NewsDVADaVita4.2684 of 5 stars$133.33-0.1%$166.33+24.8%+4.5%$10.66B$12.82B12.4170,000Upcoming EarningsAnalyst UpgradePositive NewsCHEChemed4.4813 of 5 stars$575.27+2.1%$667.00+15.9%-0.7%$8.42B$2.43B29.1114,200News CoveragePositive NewsCRVLCorVel0.9399 of 5 stars$111.57+1.3%N/A+38.7%$5.73B$871.31M65.674,230Positive NewsAMEDAmedisys2.7458 of 5 stars$91.84+0.0%$100.75+9.7%+3.0%$3.02B$2.35B36.4720,000Earnings ReportAnalyst RevisionNews CoverageMDPediatrix Medical Group1.8724 of 5 stars$12.03+0.3%$16.75+39.2%+35.0%$1.03B$2.01B-10.027,850News CoverageAMNAMN Healthcare Services4.1975 of 5 stars$17.82+0.1%$38.67+117.0%-66.5%$677.86M$2.98B-4.614,230Analyst RevisionNews CoverageCCRNCross Country Healthcare3.5045 of 5 stars$13.91-1.6%$18.41+32.3%-19.8%$456.40M$1.34B-278.122,700Upcoming EarningsPositive NewsGBSGBSN/A$1.19-0.8%N/A-47.8%$17.72M$440,000.00-2.127 Related Companies and Tools Related Companies Quest Diagnostics Competitors Laboratory Co. of America Competitors DaVita Competitors Chemed Competitors CorVel Competitors Amedisys Competitors Pediatrix Medical Group Competitors AMN Healthcare Services Competitors Cross Country Healthcare Competitors GBS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IDXG) was last updated on 4/27/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Interpace Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Interpace Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
